ACT Capital Management’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$142K	–	81
2022 Q1	$142K	Sell	10,000 -3,500	-26%	-$49.7K	0.15%	60
2021 Q4	$286K	Sell	13,500 -9,500	-41%	-$201K	0.21%	57
2021 Q3	$514K	Buy	+23,000	New	+$514K	0.27%	58